Five Key Issues For The Future Of Cancer IT
If there’s one thing that’s become clear about precision medicine – and the delivery of optimal care based in science – it will require super technology. This need is especially urgent in oncology.
Why Women And Doctors Need To Know More About DCIS
DCIS accounts for approximately 1 in 5 breast cancer-ish diagnoses in the United States. The practical problem with DCIS is that most oncologists, surgical and medical, will admit they’re not sure what to do about it.
Can Journalists Be Too Skeptical About Progress Against Cancer?
On Twitter this week, I happened upon a discussion having to do with the possibility of curing cancer.
How To Avoid Overdiagnosis And Overtreatment Of Breast Cancer
If overtreatment is the problem, the solution is not by avoidance of breast cancer detection, but by better education of physicians and patients.
Recent Studies Of Mammography Use Shockingly Old Data
Researchers today are analyzing our grandmothers’ mammograms to inform women’s health and screening decisions today.
All Women Should Have Access To Ultrasound Screening For Breast Cancer
Radiologists who publish academic papers on breast imaging may be influenced by idiosyncrasies in training, what machines their practices own or hospitals happen to have purchased, anecdotal experiences and personal skills.
Mandatory Reporting Of Breast Density In Screening Mammograms. Why The Controversy?
Women have every right to know if they have dense breasts and if they’re at increased risk for a hidden tumor.
Landscape Analysis Reveals How Little Is Known, Or Said, About Metastatic Breast Cancer
Many patients living with metastatic breast cancer need more help than they’re receiving, and many are reluctant to ask.
Ebola, Experimental Drugs and Informed Consent: Should Those At Risk Simply Take What The Doctor Orders?
Is it possible to apply the principle of informed consent when giving experimental drugs during a rapid and devastating epidemic?
Breast Cancer Chemotherapy Varies Widely: Study Raises Questions About Early Treatment Choices
Chemotherapy treatments for early-stage breast cancer vary widely in their possible side effects. But few newly-diagnosed patients press their oncologists about those differences.
Time for Informed Consent: The FDA Considers Risks of Power Morcellators in Fibroid Surgery
Last week, a panel convened by the FDA deliberated over the risks and benefits of using power morcellators in gynecological surgery. In April, the agency issued an alert cautioning providers that the tools could spread malignant cells from an occult malignancy.
How Much Do You Want Your Doctors To Say About Risks of Treatment?
This kind of paternalism, when a doctor assesses the risks and benefits, and spares the patient’s “knowing” seems anachronistic. But it may, still, be what many people are looking for when and if they get a serious illness.